Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Knox

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pathology Oncology Research : POR|January 1, 1997
Prodrugs in Cancer ChemotherapyRichard J Knox, Tom A Connors
Dalton Transactions (Cambridge, England : 2003)|October 2, 2008
Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugsOlivia R Allen, Richard J Knox, Patrick C McGowan
Current Pharmaceutical Design|October 8, 2003
CB 1954: from the Walker tumor to NQO2 and VDEPTRichard J Knox, Philip J Burke, Shiuan Chen, et al.
Biochemical Pharmacology|October 9, 2008
Nitroreductase from Bacillus licheniformis: a stable enzyme for prodrug activationCaroline D Emptage, Richard J Knox, Michael J Danson, et al.
Bioorganic & Medicinal Chemistry|September 3, 2003
Nitrobenzocyclophosphamides as potential prodrugs for bioreductive activation: synthesis, stability, enzymatic reduction, and antiproliferative activity in cell cultureZhuorong Li, Jiye Han, Yongying Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The synthesis of 2-nitroaryl-1,2,3,4-tetrahydroisoquinolines, nitro-substituted 5,6-dihydrobenzimidazo[2,1-a]isoquinoline N-oxides and related heterocycles as potential bioreducible substrates for the enzymes NAD(P)H: quinone oxidoreductase 1 and E. coli nitroreductasePhilip J Burke, Lai Chun Wong, Terence C Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Studies relating to the synthesis, enzymatic reduction and cytotoxicity of a series of nitroaromatic prodrugsPhilip J Burke, Lai Chun Wong, Terence C Jenkins, et al.
Dalton Transactions (Cambridge, England : 2003)|November 10, 2007
Functionalised cyclopentadienyl titanium compounds as potential anticancer drugsOlivia R Allen, Andrew L Gott, John A Hartley, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activationYongying Jiang, Jiye Han, Chengzhi Yu, et al.
Biochemical Pharmacology|August 12, 2009
Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutationsMansooreh Jaberipour, Simon O Vass, Christopher P Guise, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pathology Oncology Research : POR|January 1, 1997
Prodrugs in Cancer ChemotherapyRichard J Knox, Tom A Connors
Dalton Transactions (Cambridge, England : 2003)|October 2, 2008
Functionalised cyclopentadienyl zirconium compounds as potential anticancer drugsOlivia R Allen, Richard J Knox, Patrick C McGowan
Current Pharmaceutical Design|October 8, 2003
CB 1954: from the Walker tumor to NQO2 and VDEPTRichard J Knox, Philip J Burke, Shiuan Chen, et al.
Biochemical Pharmacology|October 9, 2008
Nitroreductase from Bacillus licheniformis: a stable enzyme for prodrug activationCaroline D Emptage, Richard J Knox, Michael J Danson, et al.
Bioorganic & Medicinal Chemistry|September 3, 2003
Nitrobenzocyclophosphamides as potential prodrugs for bioreductive activation: synthesis, stability, enzymatic reduction, and antiproliferative activity in cell cultureZhuorong Li, Jiye Han, Yongying Jiang, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2011
The synthesis of 2-nitroaryl-1,2,3,4-tetrahydroisoquinolines, nitro-substituted 5,6-dihydrobenzimidazo[2,1-a]isoquinoline N-oxides and related heterocycles as potential bioreducible substrates for the enzymes NAD(P)H: quinone oxidoreductase 1 and E. coli nitroreductasePhilip J Burke, Lai Chun Wong, Terence C Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Studies relating to the synthesis, enzymatic reduction and cytotoxicity of a series of nitroaromatic prodrugsPhilip J Burke, Lai Chun Wong, Terence C Jenkins, et al.
Dalton Transactions (Cambridge, England : 2003)|November 10, 2007
Functionalised cyclopentadienyl titanium compounds as potential anticancer drugsOlivia R Allen, Andrew L Gott, John A Hartley, et al.
Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activationYongying Jiang, Jiye Han, Chengzhi Yu, et al.
Biochemical Pharmacology|August 12, 2009
Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutationsMansooreh Jaberipour, Simon O Vass, Christopher P Guise, et al.
Pageof 2